# OSTF1

## Overview
OSTF1, or osteoclast stimulating factor 1, is a gene that encodes a protein involved in the regulation of bone metabolism, particularly through its role in osteoclast activity and bone resorption. The protein encoded by OSTF1 is an intracellular signaling molecule characterized by the presence of a c-Src homology 3 (SH3) domain and ankyrin repeats, which facilitate its interactions with other proteins, such as the non-receptor tyrosine kinase c-Src, crucial for osteoclast function (Vermeren2017Osteoclast; Reddy1998Isolation). OSTF1 is expressed in various human tissues, indicating its broad functional significance beyond bone metabolism (Li2004Crystallization). The protein's involvement in intracellular signaling pathways underscores its role in cytoskeletal organization and cellular adhesion, contributing to the modulation of bone density and remodeling (Cook2023Comparative). Studies in knockout mice have demonstrated that the absence of OSTF1 leads to increased trabecular bone mass, highlighting its critical function in maintaining bone homeostasis (Vermeren2017Osteoclast).

## Structure
The OSTF1 gene encodes the osteoclast-stimulating factor, a 28 kDa peptide involved in osteoclast formation and bone resorption. The protein contains a c-Src homology 3 (SH3) domain and ankyrin repeats, which are crucial for its function. The SH3 domain is indicative of its role in protein-protein interactions, particularly with c-Src, a tyrosine kinase involved in cellular signaling pathways. Ankyrin repeats are known for binding integral membrane proteins and are confined to specific membrane domains, suggesting a role in cellular localization and interaction (Li2004Crystallization).

The crystallization of the OSTF1 protein was achieved using the hanging-drop vapor-diffusion method, resulting in primitive orthorhombic crystals that belong to the P222 space group. This structural information provides insights into the protein's three-dimensional conformation, which is essential for understanding its functional interactions (Li2004Crystallization).

OSTF1 may also interact with the survival motor neuron (SMN) protein, which is relevant to spinal muscular atrophy, indicating a broader role in cellular signaling mechanisms. The protein's mRNA is ubiquitously expressed in multiple human tissues, suggesting its widespread functional importance (Li2004Crystallization).

## Function
OSTF1, or osteoclast stimulating factor 1, is a gene that encodes a protein involved in bone metabolism, particularly in the regulation of osteoclast activity and bone resorption. The OSTF1 protein is an intracellular protein that contains an SH3 domain and ankyrin repeats, which are indicative of its role in protein-protein interactions and intracellular signaling pathways (Vermeren2017Osteoclast; Reddy1998Isolation). 

In healthy human cells, OSTF1 is expressed in osteoclasts, where it indirectly enhances osteoclast formation and bone resorption. It interacts with several intracellular proteins, including the non-receptor tyrosine kinase c-Src, which is crucial for osteoclast function and bone resorption (Vermeren2017Osteoclast; Reddy1998Isolation). OSTF1 is not secreted but functions within the cell, suggesting its role in intracellular signaling pathways that regulate cytoskeletal organization and cellular adhesion (Cook2023Comparative; Reddy1998Isolation).

The protein is involved in the modulation of bone density and remodeling, as evidenced by studies showing that its absence in knockout mice leads to increased trabecular bone mass, indicating its role in bone resorption (Vermeren2017Osteoclast). This suggests that OSTF1 plays a critical role in maintaining bone homeostasis by balancing bone formation and resorption processes.

## Clinical Significance
The OSTF1 gene, also known as Osteoclast Stimulation Factor 1, is implicated in several clinical conditions due to its role in bone resorption and interaction with various proteins. Variations in OSTF1 have been associated with a range of diseases, although these correlations do not establish direct causation. Genome-wide association studies have linked OSTF1 to coronary artery diseases, body mass index, Alzheimer's disease, multiple sclerosis, and nonalcoholic fatty liver disease (Vermeren2017Osteoclast).

OSTF1 is part of a chromosomal region deleted in a microdeletion syndrome at 9q21.13, which is associated with mild mental retardation, autism-spectrum disorder, small stature, speech delay, and epileptic seizures (Vermeren2017Osteoclast). The gene's interaction with proteins such as F-actin, c-Src, and Cbl is crucial for its bone-resorption properties, and disruptions in these interactions may contribute to bone density disorders (Vermeren2017Osteoclast).

In a knockout mouse model, the absence of OSTF1 resulted in increased trabecular bone mass and a mild form of osteopetrosis, indicating its role in bone density regulation (Vermeren2017Osteoclast). This suggests that alterations in OSTF1 expression or function could potentially lead to bone-related diseases in humans.

## Interactions
OSTF1 (osteoclast stimulating factor 1) is known to interact with several intracellular proteins that play significant roles in bone resorption and cytoskeletal organization. It interacts with F-actin, a component crucial for maintaining cell shape and motility, and the non-receptor tyrosine kinase c-Src, which is involved in signaling pathways that regulate osteoclast activity (Vermeren2017Osteoclast). OSTF1 also associates with the E3 ubiquitin-protein ligase Casitas B-lineage lymphoma (Cbl), which is important for the bone-resorption properties of osteoclast-like cells (Vermeren2017Osteoclast).

In addition to these interactions, OSTF1 has been shown to interact with Myosin 1e, a protein involved in cytoskeletal reorganization and vesicular trafficking. This interaction is significant as Myosin 1e is also involved in the secretion of the chemokine CCL2, which affects bone mass (Vermeren2017Osteoclast). OSTF1 also interacts with AP3D1, a component of the AP3 vesicular trafficking complex, which influences peptide hormone release (Vermeren2017Osteoclast). These interactions highlight OSTF1's role in modulating bone density and its involvement in complex cellular processes related to bone metabolism.


## References


[1. (Cook2023Comparative) Jennifer Cook, Elizabeth S. Greene, Alison Ramser, Garrett Mullenix, Jalila S. Dridi, Rohana Liyanage, Robert Wideman, and Sami Dridi. Comparative- and network-based proteomic analysis of bacterial chondronecrosis with osteomyelitis lesions in broiler’s proximal tibiae identifies new molecular signatures of lameness. Scientific Reports, April 2023. URL: http://dx.doi.org/10.1038/s41598-023-33060-y, doi:10.1038/s41598-023-33060-y. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-023-33060-y)

[2. (Li2004Crystallization) Ming Li, Zhaohui Meng, Yanhui Xu, Zhiyong Lou, and Zihe Rao. Crystallization and preliminary x-ray crystallographic analysis of osteoclast-stimulating factor. Acta Crystallographica Section F Structural Biology and Crystallization Communications, 61(1):128–130, December 2004. URL: http://dx.doi.org/10.1107/s1744309104031653, doi:10.1107/s1744309104031653. This article has 0 citations.](https://doi.org/10.1107/s1744309104031653)

[3. (Vermeren2017Osteoclast) Matthieu Vermeren, Rodanthi Lyraki, Sachin Wani, Rannar Airik, Omar Albagha, Richard Mort, Friedhelm Hildebrandt, and Toby Hurd. Osteoclast stimulation factor 1 (ostf1) knockout increases trabecular bone mass in mice. Mammalian Genome, 28(11–12):498–514, September 2017. URL: http://dx.doi.org/10.1007/s00335-017-9718-3, doi:10.1007/s00335-017-9718-3. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00335-017-9718-3)

[4. (Reddy1998Isolation) Sakamuri Reddy, Rowena Devlin, Cheikh Menaa, Riko Nishimura, Sun Jin Choi, Mark Dallas, Toshi Yoneda, and G. David Roodman. Isolation and characterization of a cdna clone encoding a novel peptide (osf) that enhances osteoclast formation and bone resorption. Journal of Cellular Physiology, 177(4):636–645, December 1998. URL: http://dx.doi.org/10.1002/(sici)1097-4652(199812)177:4<636::aid-jcp14>3.0.co;2-h, doi:10.1002/(sici)1097-4652(199812)177:4<636::aid-jcp14>3.0.co;2-h. This article has 44 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/(sici)1097-4652(199812)177:4)